Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. En savoir plus sur Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA.
Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways. En savoir plus sur Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways.
Different Effects of Social Support on Adolescent Smoking and the Mediation by Smartphone Dependence. En savoir plus sur Different Effects of Social Support on Adolescent Smoking and the Mediation by Smartphone Dependence.
Comparison of body composition assessment by DXA and BIA according to the body mass index: A retrospective study on 3655 measures. En savoir plus sur Comparison of body composition assessment by DXA and BIA according to the body mass index: A retrospective study on 3655 measures.
Reduced Cancer Incidence in Huntington''s Disease: Analysis in the Registry Study. En savoir plus sur Reduced Cancer Incidence in Huntington''s Disease: Analysis in the Registry Study.
Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort. En savoir plus sur Evaluation of the adequacy of drug prescriptions in patients with chronic kidney disease: results from the CKD-REIN cohort.
Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients. En savoir plus sur Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.
[ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology]. En savoir plus sur [ypT0N0 after neoadjuvant chemotherapy and cystectomy for muscle-invasive bladder cancer: Incidence and prognosis. A review from the Bladder group of the French Committee of Oncology].
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs de la voie excrétrice supérieure French ccAFU guidelines — Update 2018—2020: Upper tract urothelial carcinoma En savoir plus sur RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs de la voie excrétrice supérieure French ccAFU guidelines — Update 2018—2020: Upper tract urothelial carcinoma
RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs de la vessie French ccAFU guidelines — Update 2018—2020: Bladder cancer En savoir plus sur RETRACTED: Recommandations françaises du Comité de Cancérologie de l’AFU — Actualisation 2018—2020 : tumeurs de la vessie French ccAFU guidelines — Update 2018—2020: Bladder cancer